Search Results - Mathieu Seynaeve
- Showing 1 - 2 results of 2
-
1
Low‐dose psilocybin in short‐lasting unilateral neuralgiform headache attacks: results from an open‐label phase Ib ascending dose study by James Rucker, Matt Butler, Sadie Hambleton, Catherine Bird, Mathieu Seynaeve, Sanjay Cheema, Kete Campbell‐Coker, Carolina Maggio, Fiona Dunbar, Giorgio Lambru, Manjit Matharu
Published 2024Get full text
Artículo Open Access -
2
5‐Methoxy‐ N , N ‐dimethyltryptamine (5‐MeO‐DMT) for alcohol use disorder: An open‐label, phase 2, proof‐of‐concept, clinical trial by John Marsden, Michael Kelleher, Fiona Dunbar, Anna O. Ermakova, Luke Mitcheson, Claire Roberts, James J. Rucker, Gemma Scott, Ivan Saeger, Francesca Small, Mathieu Seynaeve
Published 2025Get full text
Artículo Open Access